½ñÈÕ¶¯Ì¬ ·µ»ØÊ×Ò³
»áÔ±×¢²á µÇ¼ ÉúÎïͨ¿ìѶÃâ·Ñ¶©ÔÄ
  • Ê×Ò³ ½ñÈÕ¶¯Ì¬ È˲ÅÊг¡ Ð¼¼ÊõרÀ¸ Öйú¿ÆÑ§ÈË ÔÆÕ¹Ì¨
    BioHot
    • ¶¨ÖÆÎÒµÄBioHot
    • ½øÈëÎÒµÄBioHot
    • ½øÈëÎҵÉ
    • Ö×Áö°©Ö¢Ñо¿
    • ÃâÒß/»ùÒò/ϸ°ûÁÆ·¨
    • Éñ¾­ÉúÎïѧ
    • ½¡¿µÓë¼²²¡
    • Ë¥ÀÏ»úÖÆÓ볤ÊÙ
    • µ¥Ï¸°û¼¼Êõ
    • »ùÒò±à¼­-CRISPR
    • RNAÑо¿
    • ³¦µÀ¾úÓëÈËÌå΢Éú̬
    • ϸ°û´úл
    • AIÉúÎïÐÅϢѧ
    • COVID
    ÔÆ½²ÌÃÖ±²¥ »áÕ¹ÖÐÐÄ ÌØ¼ÛרÀ¸ ¼¼Êõ¿ìѶ Ãâ·ÑÊÔÓÃ

  • ÉúÎïͨ¹Ù΢
    ÅãÄãץסÉúÃü¿Æ¼¼
    Ìø¶¯µÄÂö²«

ÉúÎïͨÊ×Ò³  >  ½ñÈÕ¶¯Ì¬  >  ÕýÎÄ

ºÉÀ¼Ñ£ÔÎÖ¢×´Á¿±í£¨¼ò°æ£©µÄ¿çÎÄ»¯ÑéÖ¤£ºÎ¬¶È½á¹¹¡¢ÐŶÈÒÔ¼°Ö¢×´±¨¸æÖеÄÎÄ»¯²îÒì

¡¶Journal of Patient-Reported Outcomes¡·£ºCross-cultural validation of the Dutch Vertigo Symptom Scale ¨C Short Form: dimensionality, reliability and cultural differences in symptom reporting

¡¾×ÖÌ壺 ´ó ÖРС ¡¿ ʱ¼ä£º2026Äê06ÔÂ12ÈÕ À´Ô´£ºJournal of Patient-Reported Outcomes 2.9

±à¼­ÍƼö£º

¡¡¡¡ÕªÒª±³¾°¡¶Ñ£ÔÎÖ¢×´Á¿±í¼ò±í¡·£¨VSS-SF£©ÊÇÒ»Öֹ㷺ÓÃÓÚ²âÁ¿Í·ÔκÍÑ£ÔεÈǰ֢ͥ״µÄÎÊ¾í¡£´ó¶àÊý¿çÎÄ»¯ÑéÖ¤½ö¹Ø×¢·­ÒëºÍ»ù±¾ÐÄÀí²âÁ¿Ñ§·½Ã棬¶ÔÓÚ¿ç¹ú±È½ÏÐÔµÄÁ˽âÓÐÏÞ¡£±¾Ñо¿Ö¼ÔÚ£º£¨1£©¿ª·¢²¢ÑéÖ¤VSS-SFµÄºÉÀ¼Óï°æ±¾£»£¨2£©Ìṩ¹ØÓÚÖ¢×´±¨¸æµÄ¿çÎÄ»¯²îÒìÒÔ¼°¸ÃÁ¿±í·½·¨Ñ§ÎȽ¡ÐÔµÄмû

¡¡¡¡

ÕªÒª

±³¾°

¡¶Ñ£ÔÎÖ¢×´Á¿±í¼ò±í¡·£¨VSS-SF£©ÊÇÒ»Öֹ㷺ÓÃÓÚ²âÁ¿Í·ÔκÍÑ£ÔεÈǰ֢ͥ״µÄÎÊ¾í¡£´ó¶àÊý¿çÎÄ»¯ÑéÖ¤½ö¹Ø×¢·­ÒëºÍ»ù±¾ÐÄÀí²âÁ¿Ñ§·½Ã棬¶ÔÓÚ¿ç¹ú±È½ÏÐÔµÄÁ˽âÓÐÏÞ¡£±¾Ñо¿Ö¼ÔÚ£º£¨1£©¿ª·¢²¢ÑéÖ¤VSS-SFµÄºÉÀ¼Óï°æ±¾£»£¨2£©Ìṩ¹ØÓÚÖ¢×´±¨¸æµÄ¿çÎÄ»¯²îÒìÒÔ¼°¸ÃÁ¿±í·½·¨Ñ§ÎȽ¡ÐÔµÄмû½â¡£

·½·¨ÂÛ

×ñÑ­¹ú¼ÊÖ¸ÄÏ£¬ÎÒÃǶÔVSS-SFµÄºÉÀ¼Óï°æ±¾½øÐÐÁË·­ÒëºÍÓïÑÔѧÑéÖ¤¡£Ëæºó£¬ÎÒÃÇʹÓÃË«Òò×ÓÄ£ÐͱȽÏÁËÆäά¶È½á¹¹¡¢ÐŶÈÒÔ¼°ÏîÄ¿Çø·Ö¶È£¨DIF£©£¬ÒÔ¼ìÑéÆä±¾ÖÊÉϵĵ¥Î¬ÐÔ¡£Ñо¿Êý¾ÝÀ´×Ô50Ëê¼°ÒÔÉϵÄÂýÐÔǰ֢ͥ״»¼Õߣ¬ÕâЩ»¼Õß²ÎÓëÁËÓ¢¹ú£¨n=296£©ºÍºÉÀ¼£¨n=322£©µÄËæ»ú¶ÔÕÕÊÔÑé¡£

½á¹û

ºÉÀ¼Óï°æ±¾µÄÎÊ¾í±»ÊÜ·ÃÕ߽ϺõØÀí½â¡£ÐÄÀí²âÁ¿Ñ§ÆÀ¹À±íÃ÷£¬Á½¸ö°æ±¾¶¼¾ßÓб¾ÖÊÉϵĵ¥Î¬ÐÔ£¨½á¹¹ÏµÊýÆ«²î<15%£©¡£ÐŶȷdz£ÓÅÐ㣨ºÉÀ¼Óï°æ±¾×ÜÐŶÈΪ0.920£¬Ó¢¹úÓï°æ±¾Îª0.956£©¡£ÏîÄ¿Çø·Ö¶È·ÖÎöÏÔʾÁËÎÄ»¯²îÒ죺ºÉÀ¼»¼Õß±¨¸æ¶ñÐÄ/Ż͵ÄÖ¢×´½ÏÉÙ£¬µ«¼´Ê¹ÔÚͬһ֢״ˮƽÏ£¬±¨¸æ²»ÎȵÄÖ¢×´½Ï¶à¡£È»¶ø£¬ÕâЩ²îÒì¶Ô×Ü·ÖµÄÓ°Ïì¿ÉÒÔºöÂÔ²»¼Æ¡£

½áÂÛ

ºÉÀ¼Óï°æ±¾µÄVSS-SF¾ßÓÐÓÐЧÐԺͿɿ¿ÐÔ£¬ÆäµÃ·ÖÓëÓ¢¹úÓï°æ±¾Ö±½Ó¿É±È¡£³ýÁË·­Ò빤×÷Ö®Í⣬ÕâÏîÑо¿»¹Õ¹Ê¾ÁËÏȽøÐÄÀí²âÁ¿·½·¨ÈçºÎ½ÒʾVSS-SFµÄÎȽ¡ÐÔÒÔ¼°Ö¢×´¸ÐÖªÖеÄϸ΢ÎÄ»¯²îÒ죬´Ó¶øÔöÇ¿ÁËÆäÔÚ¿ç¹úÑо¿ºÍÁÙ´²Êµ¼ùÖеÄÓ¦ÓüÛÖµ¡£

±³¾°

¡¶Ñ£ÔÎÖ¢×´Á¿±í¼ò±í¡·£¨VSS-SF£©ÊÇÒ»Öֹ㷺ÓÃÓÚ²âÁ¿Í·ÔκÍÑ£ÔεÈǰ֢ͥ״µÄÎÊ¾í¡£´ó¶àÊý¿çÎÄ»¯ÑéÖ¤½ö¹Ø×¢·­ÒëºÍ»ù±¾ÐÄÀí²âÁ¿Ñ§·½Ã棬¶ÔÓÚ¿ç¹ú±È½ÏÐÔµÄÁ˽âÓÐÏÞ¡£±¾Ñо¿Ö¼ÔÚ£º£¨1£©¿ª·¢²¢ÑéÖ¤VSS-SFµÄºÉÀ¼Óï°æ±¾£»£¨2£©Ìṩ¹ØÓÚÖ¢×´±¨¸æµÄ¿çÎÄ»¯²îÒìÒÔ¼°¸ÃÁ¿±í·½·¨Ñ§ÎȽ¡ÐÔµÄмû½â¡£

·½·¨ÂÛ

×ñÑ­¹ú¼ÊÖ¸ÄÏ£¬ÎÒÃǶÔVSS-SFµÄºÉÀ¼Óï°æ±¾½øÐÐÁË·­ÒëºÍÓïÑÔѧÑéÖ¤¡£Ëæºó£¬ÎÒÃÇʹÓÃË«Òò×ÓÄ£ÐͱȽÏÁËÆäά¶È½á¹¹¡¢ÐŶÈÒÔ¼°ÏîÄ¿Çø·Ö¶È£¨DIF£©£¬ÒÔ¼ìÑéÆä±¾ÖÊÉϵĵ¥Î¬ÐÔ¡£Ñо¿Êý¾ÝÀ´×Ô50Ëê¼°ÒÔÉϵÄÂýÐÔǰ֢ͥ״»¼Õߣ¬ÕâЩ»¼Õß²ÎÓëÁËÓ¢¹ú£¨n=296£©ºÍºÉÀ¼£¨n=322£©µÄËæ»ú¶ÔÕÕÊÔÑé¡£

½á¹û

ºÉÀ¼Óï°æ±¾µÄÎÊ¾í±»ÊÜ·ÃÕ߽ϺõØÀí½â¡£ÐÄÀí²âÁ¿Ñ§ÆÀ¹À±íÃ÷£¬Á½¸ö°æ±¾¶¼¾ßÓб¾ÖÊÉϵĵ¥Î¬ÐÔ£¨½á¹¹ÏµÊýÆ«²î<15%£©¡£ÐŶȷdz£ÓÅÐ㣨ºÉÀ¼Óï°æ±¾×ÜÐŶÈΪ0.920£¬Ó¢¹úÓï°æ±¾Îª0.956£©¡£ÏîÄ¿Çø·Ö¶È·ÖÎöÏÔʾÁËÎÄ»¯²îÒ죺ºÉÀ¼»¼Õß±¨¸æ¶ñÐÄ/Ż͵ÄÖ¢×´½ÏÉÙ£¬µ«¼´Ê¹ÔÚͬһ֢״ˮƽÏ£¬±¨¸æ²»ÎȵÄÖ¢×´½Ï¶à¡£È»¶ø£¬ÕâЩ²îÒì¶Ô×Ü·ÖµÄÓ°Ïì¿ÉÒÔºöÂÔ²»¼Æ¡£

½áÂÛ

ºÉÀ¼Óï°æ±¾µÄVSS-SF¾ßÓÐÓÐЧÐԺͿɿ¿ÐÔ£¬ÆäµÃ·ÖÓëÓ¢¹úÓï°æ±¾Ö±½Ó¿É±È¡£³ýÁË·­Ò빤×÷Ö®Í⣬ÕâÏîÑо¿»¹Õ¹Ê¾ÁËÏȽøÐÄÀí²âÁ¿·½·¨ÈçºÎ½ÒʾVSS-SFµÄÎȽ¡ÐÔÒÔ¼°Ö¢×´¸ÐÖªÖеÄϸ΢ÎÄ»¯²îÒ죬´Ó¶øÔöÇ¿ÁËÆäÔÚ¿ç¹úÑо¿ºÍÁÙ´²Êµ¼ùÖеÄÓ¦ÓüÛÖµ¡£

Ïà¹ØÐÂÎÅ
ÉúÎïͨ΢ÐŹ«ÖÚºÅ
ÉúÎïͨÐÂÀË΢²©
΢ÐÅ
ÐÂÀË΢²©
ÎÒҪͶ¸å
  • ËÑË÷
  • ¹ú¼Ê
  • ¹úÄÚ
  • ÈËÎï
  • ²úÒµ
  • Èȵã
  • ¿ÆÆÕ

ÈÈËÑ£ºÇ°Í¥Ö¢×´Î¯ÍÐÆÀ¹À|µ¥Î¬ÐÔÐÄÀí¼ÆÁ¿|ÐŶÈÎȶ¨ÐÔ|ÎÄ»¯²îÒì|·½·¨Ñ§ÑéÖ¤|ÁÙ´²ÊÊÓÃÐÔ ÖÐÎÄ|ǰ֢ͥ״Á¿±í|ÎÄ»¯²îÒì|¿çÓïÑÔÄÜÁ¦|ÐÄÀí²âÁ¿Ñ§|ÁÙ´²Ð§¶È ½üʳ¹ÜÉú³¤µÄ»ùÒòÍ»±ä|ͬԴÎ︲¸Ç|±äÒì·ÖÐÍ|ÁÙ´²±íÐÍ|ÒÅ´«ÒìÖÊÐÔ|Éú´æÇ÷ÊÆ

ÈȵãÅÅÐÐ

    ½ñÈÕ¶¯Ì¬ | È˲ÅÊг¡ | м¼ÊõרÀ¸ | Öйú¿ÆÑ§ÈË | ÔÆÕ¹Ì¨ | BioHot | ÔÆ½²ÌÃÖ±²¥ | »áÕ¹ÖÐÐÄ | ÌØ¼ÛרÀ¸ | ¼¼Êõ¿ìѶ | Ãâ·ÑÊÔÓÃ

    °æÈ¨ËùÓÐ ÉúÎïͨ

    Copyright© eBiotrade.com, All Rights Reserved

    ÁªÏµÐÅÏ䣺

    ÔÁICP±¸09063491ºÅ